KTTA - Pasithea Therapeutics Projected Future Earnings

Pasithea Therapeutics (KTTA) production lines for neuro-drugs are operating according to clinical plans. This revenue projection chart reflects market expectations, where the current level is approximately . The business strategy relies on total outsourcing of molecule synthesis via CROs. Simultaneously, the company is building a comprehensive mental health ecosystem that integrates ketamine centers with the development of antidepressants.
Financial and market metric breakdowns for Pasithea Therapeutics Corp (KTTA)

Projected profit reflects the issuer's expected annual aggregate financial result. The model calculates cash generation potential while excluding short-term market volatility. By analyzing the future profit chart of Pasithea Therapeutics (KTTA), an investor can assess the stability of the fundamental trend. For Pasithea Therapeutics (KTTA), this indicator is based exclusively on the organic development of the neuro-pipeline. The absence of external acquisitions ensures that the indicator's dynamics directly reflect the efficiency of internal research.